DiaGenic ASA (OSE:DIAG) and Pfizer Inc [NYSE: PFE] signed an agreement for explorative R&D collaboration to identify biomarkers in early stages of Alzheimer's disease (AD) using DiaGenic's patented gene expression technology and its blood samples from ongoing clinical studies. The companies...